HC Wainwright & Co. reiterated coverage on Turning Point with a new price target
$TPTX
Biotechnology: Pharmaceutical Preparations
Health Care
HC Wainwright & Co. reiterated coverage of Turning Point with a rating of Buy and set a new price target of $162.00 from $178.00 previously